National Fertilizers Ltd. - Research Center
523630 NFL Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Sales | 7,580.93 | 5,659.64 | 5,051.23 | 6,267.84 | 10,137.34 |
| Operating profit | 315.16 | -54.65 | -8.54 | -330.82 | 937.02 |
| Interest | 49.86 | 39.31 | 104.22 | 83.63 | 94.11 |
| Gross profit | 282.65 | -62.40 | -104.24 | -270.45 | 875.96 |
| EPS (Rs) | 2.85 | -2.31 | -2.93 | -5.48 | 12.00 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Other income | 17.35 | 31.56 | 8.52 | 144.00 | 33.05 |
| Stock adjustment | -57.88 | 411.46 | 354.77 | -384.36 | 302.42 |
| Raw material | 2,086.12 | 1,881.85 | 1,735.53 | 2,258.09 | 2,805.30 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 154.49 | 160.42 | 158.28 | 122.93 | 213.28 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 5,083.04 | 3,260.56 | 2,811.19 | 4,602.00 | 5,879.32 |
| Provisions made | - | - | - | - | - |
| Depreciation | 92.42 | 90.43 | 87.11 | 88.92 | 89.63 |
| Taxation | 50.21 | -39.73 | -47.42 | -90.50 | 197.71 |
| Net profit / loss | 140.02 | -113.10 | -143.93 | -268.87 | 588.62 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 490.58 | 490.58 | 490.58 | 490.58 | 490.58 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 4.16 | -0.97 | -0.17 | -5.28 | 9.24 |
| GPM (%) | 3.72 | -1.10 | -2.06 | -4.22 | 8.61 |
| NPM (%) | 1.84 | -1.99 | -2.84 | -4.19 | 5.79 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis